Navigation Links
'Non-invasive' cultivar? Buyer beware
Date:10/6/2011

Cultivars of popular ornamental woody plants that are being sold in the United States as non-invasive are probably anything but, according to an analysis by botanical researchers published in the October issue of BioScience. Tiffany M. Knight of Washington University in St. Louis, Missouri, and her coauthors at the Chicago Botanic Garden write that the claims of environmental safety are in most cases based on misleading demographic evidence that greatly underestimates the plants' invasive potential. What is more, the offspring of cultivars do not usually "breed true" and may be more fecund than their parents, especially if they cross with plants from nearby feral populations.

Many invasive plants were once ornamental cultivars, because the characteristics that the "green" industry looks for are the same ones that make a plant potentially invasive -- being adaptable to wide range of conditions, forming dense stands good for erosion control, and having a long flowering period, for example. In recent years the nursery and horticultural industries have responded by creating cultivars of top-selling plants that produce reduced numbers of viable seed and are advertized as "safe to natural areas." Such cultivars of Japanese barberry, buckthorn, and burning bush are now widely sold, as they avoid bans on growing invasive species.

Yet simple population modeling demonstrates that reductions of even 95 percent in the number of viable seed will leave a long-lived species quite capable of spreading -- and many of the new cultivars do not achieve even that much of a reduction. More sophisticated modeling would likely reveal even stronger invasive potential of the "safe" cultivars. Knight and her co-authors conclude that only completely sterile cultivars can be considered truly safe without further testing, and that other types should be tested for breeding true and having a low growth rate before they are sold as non-invasive.


'/>"/>
Contact: Tim Beardsley
tbeardsley@aibs.org
703-654-2500 x326
American Institute of Biological Sciences
Source:Eurekalert

Page: 1

Related biology news :

1. Potential for non-invasive brain tumor treatment
2. Buyer beware: Dangerous levels of lead found in used consumer products
3. Amphibians: Beware young beetles deadly siren call
4. Beware of predatory male black bears
5. Coffee, energy drinkers beware: Many mega-sized drinks loaded with sugar, MU nutrition expert says
6. Urban gardeners beware: There may be lead in your soil and food
7. NASA scientist publishes new book: Coming Climate Crisis? Consider the Past, Beware the Big Fix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
Breaking Biology News(10 mins):
(Date:4/19/2017)... ... , ... A number of new instruments have recently emerged to accommodate different ... Protein and Cell Analysis Education Webinar Series , will focus on advances in the ... future applications. , Many flow cytometers have unique capabilities and the Attune NxT ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics Announces Completion of ... Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial , Nobilis ... clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in the treatment of ...
(Date:4/19/2017)... ... April 19, 2017 , ... As part of the ... to novices as well as experienced users, attendees will gain a better understanding ... tests. , Hemostasis testing quality is determined by preanalytical variables which encompass ...
(Date:4/19/2017)... WESTMINSTER, Colo. , April 19, 2017 ... specialty finance firm that provides senior debt to ... the closing of a $20 million senior secured ... orthobiologics company engaged in the development and commercialization ... of orthopedic injuries. Cerapedics, lead product, ...
Breaking Biology Technology: